A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

NCT03491709 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: anti-EGFR monoclonal antibody
DRUG: Cetuximab injection

Sponsor

Dragonboat Biopharmaceutical Company Limited

Collaborators

[object Object]